The latest therapies for chronic lymphocytic leukemia are effective, including new monoclonal antibodies and targeted drugs.
Chronic lymphocytic leukemia treatment is specific and not all patients require immediate treatment after diagnosis. The treatment cycle should follow the specific individual treatment and follow the doctor’s instructions. There are continuous and intermittent treatments depending on the drugs and treatment methods.
1. New monoclonal antibodies, including rituximab.
2. New targeted drugs including Ibrutinib, Zebutinib, etc.
Chronic lymphocytic leukemia is a slow-progressing proliferative tumor of mature B lymphocytes, characterized by the presence of a large number of mature B lymphocytes in lymphoid tissues such as peripheral blood, bone marrow, spleen and lymph nodes, etc. The etiology and pathogenesis of the disease are not yet fully clarified. If chronic lymphocytic leukemia occurs, it is necessary to seek medical treatment in time and under the guidance of doctors.